Dare Bioscience Inc (DARE)
0.312
-0.02
(-5.43%)
USD |
NASDAQ |
May 02, 16:00
0.312
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.3189 |
| September 30, 2020 | -0.265 |
| June 30, 2020 | 1.18 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.9815 |
| September 30, 2016 | 0.8871 |
| June 30, 2016 | 0.645 |
| March 31, 2016 | 0.5147 |
| December 31, 2015 | 0.417 |
| September 30, 2015 | 0.2483 |
| June 30, 2015 | 0.2124 |
| March 31, 2015 | 0.3567 |
| December 31, 2014 | 0.0689 |
| September 30, 2014 | 0.0749 |
| June 30, 2014 | 0.0817 |
| March 31, 2014 | -0.2352 |
| December 31, 2013 | -0.1599 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.3189
Minimum
Dec 2020
1.18
Maximum
Jun 2020
0.0314
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Altimmune Inc | 0.00 |
| Verastem Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Orgenesis Inc | -1.062 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 21.28M |
| Total Liabilities (Quarterly) | 26.33M |
| Shareholders Equity (Quarterly) | -5.048M |
| Current Ratio | 0.8566 |